申请人:KYOWA HAKKO KIRIN CO., LTD.
公开号:US20130267509A1
公开(公告)日:2013-10-10
Method of treating central nervous systems disease by administering
wherein n is an integer of from 0 to 3; R
1A
is a 5-membered aromatic heterocyclic group containing at least one oxygen atom; R
2A
is —COR
8
(wherein R
8
is aryl); R
3A
is hydrogen or lower alkyl; and R
12
represents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R
1A
, R
2A
, R
3A
and R
12
are individually optionally substituted.
通过给予其中n为0到3的整数的化合物治疗中枢神经系统疾病的方法;其中R1A是一个含有至少一个氧原子的5元芳香杂环基团;R2A是—COR8(其中R8是芳基);R3A是氢或低碳基;R12代表环烷基,芳基,芳基烷基,脂环杂环基团,芳香杂环基团,脂环杂环-烷基或芳香杂环-烷基,且R1A,R2A,R3A和R12可以各自选择性地被取代。